Healthcare -
Biotechnology - NASDAQ - US
$ 18.13
6.27 %
$ 1.44 B
Market Cap
-4.2
P/E
VRDN - STOCK-BASED COMPENSATION
Stock-based Compensation VRDN - Viridian Therapeutics, Inc.
67.2 M
LAST VALUE
115.49%
2 YEAR CAGR
78.77%
5 YEAR CAGR
0.00%
10 YEAR CAGR